[Federal Register Volume 73, Number 83 (Tuesday, April 29, 2008)]
[Notices]
[Pages 23261-23262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-9283]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.

[[Page 23262]]

    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Drug Interactions.
    Date: May 15, 2008.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852(Telephone Conference Call).
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator,Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH, DHHS,Room 220, MSC 8401,6101 Executive Blvd. 
Bethesda, MD 20892-8401,301-402-6626, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA L Conflicts.
    Date: June 2, 2008.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue,Bethesda, MD 20814.
    Contact Person: Meenaxi Hiremath, PhD, Health Scientist 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse,National Institutes of Health, DHHS,6101 Executive Blvd., 
Suite 220, MSC 8401,Bethesda, MD 20892,301-402-7964, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-E Conflicts.
    Date: June 4, 2008.
    Time: 2:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Jurys Washington Hotel, 1500 New Hampshire Avenue, 
Washington, DC 20036.
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 
20892,301-451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-F Conflicts.
    Date: June 4, 2008.
    Time: 4:30 p.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Jury Washington Hotel, 1500 New Hampshire Avenue, 
Washington, DC 20036.
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs,National Institute on 
Drug Abuse, NIH,6101 Executive Blvd., Rm. 213, MSC 8401,Bethesda, MD 
20892,301-451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special
    Emphasis Panel; Center Review Committee.
    Date: July 21-23, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington DC 20037.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Program Projects Review Committee.
    Date: July 22, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Rita Liu, PhD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Center Review.
    Date: July 23-24, 2008.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street, NW., 
Washington, DC 20037.
    Contact Person: Rita Liu, PHD, Associate Director, Office of 
Extramural Affairs,National Institute on Drug Abuse, NIH, DHHS,Room 
212, MSC 8401,6101 Executive Boulevard,Bethesda, MD 20892-
8401,301.435.1388, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: April 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-9283 Filed 4-28-08; 8:45 am]
BILLING CODE 4140-01-M